Malignant Pleural Mesothelioma Upcoming Therapies
Jan 15, 2020
Malignant Pleural Mesothelioma Upcoming Therapies
The Malignant Pleural Mesothelioma Market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and Yervoy, which have shown promising anticancer activity against mesothelioma in recent clinical trials. These drugs have been approved for other indications and now are being used in mono...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
